Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Hormonal and Reproductive Unknowns No studies confirm how BPC-157 or TB-500 interact with estrogen, progesterone, or menstrual cycles
Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists
Maximum Weight Loss Retatrutide Phase 3 TRIUMPH-4 showed 28.7% weight loss at 68 weeks, substantially exceeding CagriSema's 20.4% at 68 weeks
Use case: Tendon injuries, muscle tears, joint inflammation, post-surgical recovery
Mechanistically, research has focused on BPC-157's ability to upregulate VEGF (vascular endothelial growth factor) receptor expression, promote angiogenesis at sites of injury, modulate nitric oxide synthase activity, and support the integrity of the gut lining the tissue environment from which the original protective protein was isolated
US$ 25.72
US$ 23.58
US$ 27.30
US$ 25.89
US$ 27.64
